Tempus AI, Inc.
TEM Healthcare Health Information Services
Tempus AI, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.3 billion, up 83.4% from fiscal 2024.
- Revenue
- +23.1%
- EPS
- +82.2%
- Free cash flow
- +95.7%
- Total debt
- +8.44%
Quarter to September 2026, against a year earlier
Follow TEM
Alert me
Tempus AI, Inc. (TEM) P/S ratio
As of 5 November 2026, Tempus AI, Inc. (TEM) trades at a P/S ratio of 8.5×. Over the past ten years it has ranged from 2.8× (June 2024) to 20.1× (November 2024); the current reading is higher than 43% of that period. That is above the Health Information Services industry median of 1.8× and above the Healthcare sector median of 3.5×.
P/S ratio, daily
Embed this chart
Annual newest first
| Period | P/S ratio | Change |
|---|---|---|
| FY2025 | 8.1× | 38.66% |
| FY2024 | 5.8× | 28.45% |
| FY2023 | 4.5× | 0.00% |
| FY2022 | 4.5× | — |
Quarterly newest first
| Period | P/S ratio | Change |
|---|---|---|
| Sep 2026 | 9.8× | 35.17% |
| Jun 2026 | 7.3× | 22.75% |
| Mar 2026 | 5.9× | (26.72%) |
| Dec 2025 | 8.1× | (36.66%) |
| 11 more quarters | Free account |
Against its own ten years
P/S ratio against peers
| Company | P/S ratio |
|---|---|
| BTSG BrightSpring Health Services, Inc. compare | 0.9× |
| PRVA Privia Health Group, Inc. compare | 1.2× |
| WAY Waystar Holding Corp. compare | 4.4× |
| HQY HealthEquity, Inc. compare | 6.3× |
| TEM Tempus AI, Inc. | 8.5× |
| DOCS Doximity, Inc. compare | 9.0× |
| HNGE Hinge Health Inc. compare | 12.7× |
| VEEV Veeva Systems Inc. compare | 14.5× |
| HTFL Heartflow, Inc. compare | 21.3× |
| Health Information Services industry median | 1.8× |
| Healthcare sector median | 3.5× |
| Market median | 1.9× |
What P/S ratio is
Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.
(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)
More on TEM
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Beneish M-score
- The full statement